• 1
    Garraway WM, Kirby RS. Benign prostatic hyperplasia: effects on quality of life and impact on treatment decisions. Urology 1994; 44: 62936.
  • 2
    Tsang KK, Garraway WM. Impact of benign prostatic hyperplasia on general well-being of men. Prostate 1993; 23: 17.
  • 3
    Garraway WM, Armstrong C, Auld S, King D, Simpson RJ. Follow-up of a cohort of men with untreated benign prostatic hyperplasia. Eur. Urol. 1993; 24: 31318.
  • 4
    Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338: 46971.
  • 5
    Garraway WM, Russell EB, Lee RJ et al. Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br. J. Gen. Pract. 1993; 43: 31821.
  • 6
    Lukacs B. Management of symptomatic BPH in France. who is treated and how? Eur. Urol. 1999; 36 (Suppl. 3): 1420.
  • 7
    Malaysian Medical Tribune. Fighting BPH the alfuzosin way. Malaysian Medical Tribune 1998; 60 (14): 6.
  • 8
    Kawacirk I, Cerny J, Dusck P, Safarik L, Kohler O. Subjective symptoms before and after prostate surgery. The international symptom scoring system, I-PSS. Rozhl. Chir. 1995; 74: 3348.
  • 9
    McConnell JD, Roehrborn CG. Patient selection and symptoms evaluation. In: ChisholmGD (ed.). Handbook on Benign Prostatic Hyperplasia. Merck & Co., New Jersey, 1994; 3351.
  • 10
    Naughton MJ, Wyman JF. Quality of life in geriatric patients with lower urinary tract dysfunction. Am. J. Med. Sci. 1997; 314: 21927.
  • 11
    Quek KF, Low WY, Razack AH, Loh CS. The psychological effects of treatments for lower urinary tract symptoms. BJU Int. 2000; 86: 6303.
  • 12
    Quek KF, Loh CS, Low WY, Razack AH. Quality of life assessment before and after transurethral resection of the prostate in patients with lower urinary tract symptoms. World. J. Urol. 2001; 19: 35864.
  • 13
    Melzack R. The short-form McGill pain questionnaire. Pain 1987; 30: 1917.
  • 14
    Barry MJ, Fowler FJ Jr, O'Leary MP et al. The American urological association symptom index for benign prostate hyperplasia. The measurement committee American urological association. J. Urol. 1992; 148: 154957.
  • 15
    Beck AT, Steer RA. Beck Depression Inventory: Manual. The Psychological Corporation Harcourt Brace Jovanich Inc., San Diego, 1986.
  • 16
    Spielberger CD, Gorsuch RL, Luschene A. The State-Trait Anxiety Inventory. University of South Florida, Tampa, 1986.
  • 17
    Goldberg DP, Williams P. User's Guide to the General Health Questionnaire. Windsor. nferNelson 1988.
  • 18
    Lukacs B, Leplege A, McCarthy C, Comet D. Construction and validation of a BPH specific health related quality of life scale (with special attention to sexuality) for medical outcome research studies. In: CockettATK, KhouryS, AsoY et al. (eds). Proceeding of the Second International Consultation on Benign Prostatic Hyperplasia (BPH). Scientific Communication International Ltd., Paris, 1994; 13943.
  • 19
    Brislin RW. Back-translation for cross cultural research. J. Cross. Cult. Psychol. 1970; 1: 185216.